Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Heli Nevanlinna

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Genes & Molecular Sequences

Geographic Areas

Finland

Chemicals & Drugs

Concepts & Ideas

Procedures

Case-Control Studies

Phenomena

Founder Effect

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Jiang Hai; Reinhardt H Christian; Bartkova Jirina; Tommiska Johanna; Blomqvist Carl; Nevanlinna Heli; Bartek Jiri; Yaffe Michael B; Hemann Michael T
The combined status of ATM and p53 link tumor development with therapeutic response.
Heikkinen Tuomas; Kärkkäinen Hanni; Aaltonen Kirsimari; Milne Roger L; Heikkilä Päivi; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
Aaltonen K; Amini R-M; Heikkilä P; Aittomäki K; Tamminen A; Nevanlinna H; Blomqvist C
High cyclin B1 expression is associated with poor survival in breast cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Heli Nevanlinna (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Jiang Hai; Reinhardt H Christian; Bartkova Jirina; Tommiska Johanna; Blomqvist Carl; Nevanlinna Heli; Bartek Jiri; Yaffe Michael B; Hemann Michael T
The combined status of ATM and p53 link tumor development with therapeutic response.
Genes & development 2009;23(16):1895-909.
2009: Heikkinen Tuomas; Kärkkäinen Hanni; Aaltonen Kirsimari; Milne Roger L; Heikkilä Päivi; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3214-22.
2009: Aaltonen K; Amini R-M; Heikkilä P; Aittomäki K; Tamminen A; Nevanlinna H; Blomqvist C
High cyclin B1 expression is associated with poor survival in breast cancer.
British journal of cancer 2009;100(7):1055-60.
2009: Fletcher Olivia; Johnson Nichola; Dos Santos Silva Isabel; Kilpivaara Outi; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli; Wasielewski Marijke; Meijers-Heijerboer Hanne; Broeks Annegien; Schmidt Marjanka K; Van't Veer Laura J; Bremer Michael; Dörk Thilo; Chekmariova Elena V; Sokolenko Anna P; Imyanitov Evgeny N; Hamann Ute; Rashid Muhammad U; Brauch Hiltrud; Justenhoven Christina; Ashworth Alan; Peto Julian
Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):230-4.
2008: Bartkova Jirina; Tommiska Johanna; Oplustilova Lenka; Aaltonen Kirsimari; Tamminen Anitta; Heikkinen Tuomas; Mistrik Martin; Aittomäki Kristiina; Blomqvist Carl; Heikkilä Päivi; Lukas Jiri; Nevanlinna Heli; Bartek Jiri
Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.
Molecular oncology 2008;2(4):296-316.
2008: Siltanen Sanna; Syrjäkoski Kirsi; Fagerholm Rainer; Ikonen Tarja; Lipman Peter; Mallott Jacob; Holli Kaija; Tammela Teuvo L J; Järvinen Heikki J; Mecklin Jukka-Pekka; Aittomäki Kristiina; Blomqvist Carl; Bailey-Wilson Joan E; Nevanlinna Heli; Aaltonen Lauri A; Schleutker Johanna; Vahteristo Pia
ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.
European journal of human genetics : EJHG 2008;16(8):983-91.
2008: Fagerholm Rainer; Hofstetter Barbara; Tommiska Johanna; Aaltonen Kirsimari; Vrtel Radek; Syrjäkoski Kirsi; Kallioniemi Anne; Kilpivaara Outi; Mannermaa Arto; Kosma Veli-Matti; Uusitupa Matti; Eskelinen Matti; Kataja Vesa; Aittomäki Kristiina; von Smitten Karl; Heikkilä Päivi; Lukas Jiri; Holli Kaija; Bartkova Jirina; Blomqvist Carl; Bartek Jiri; Nevanlinna Heli
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
Nature genetics 2008;40(7):844-53.
2008: Milne Roger L; Fagerholm Rainer; Nevanlinna Heli; Benítez Javier
The importance of replication in gene-gene interaction studies: multifactor dimensionality reduction applied to a two-stage breast cancer case-control study.
Carcinogenesis 2008;29(6):1215-8.
2008: Aaltonen Kirsimari; Blomqvist Carl; Amini Rose-Marie; Eerola Hannaleena; Aittomäki Kristiina; Heikkilä Päivi; Nevanlinna Heli
Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):1976-83.
2008: Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
Oncogene 2008;27(17):2501-6.
2008: Atwal Gurinder Singh; Rabadán Raúl; Lozano Guillermina; Strong Louise C; Ruijs Mariëlle W G; Schmidt Marjanka K; van't Veer Laura J; Nevanlinna Heli; Tommiska Johanna; Aittomäki Kristiina; Bougeard Gaelle; Frebourg Thierry; Levine Arnold J; Bond Gareth L
An information-theoretic analysis of genetics, gender and age in cancer patients.
PloS one 2008;3(4):e1951.
2008: Kilpivaara Outi; Rantanen Matias; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
Comprehensive analysis of NuMA variation in breast cancer.
BMC cancer 2008;8():71.
2008: Eerola Hannaleena; Heinonen Mira; Heikkilä Päivi; Kilpivaara Outi; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Ristimäki Ari; Nevanlinna Heli
Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.
Breast cancer research : BCR 2008;10(1):R17.
2008: Onay Ummiye V; Aaltonen Kirsimari; Briollais Laurent; Knight Julia A; Pabalan Noel; Kilpivaara Outi; Andrulis Irene L; Blomqvist Carl; Nevanlinna Heli; Ozcelik Hilmi
Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk.
BMC cancer 2008;8():6.
2007: Heinonen Mira; Fagerholm Rainer; Aaltonen Kirsimari; Kilpivaara Outi; Aittomäki Kristiina; Blomqvist Carl; Heikkilä Päivi; Haglund Caj; Nevanlinna Heli; Ristimäki Ari
Prognostic role of HuR in hereditary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6959-63.
2007: Schmidt Marjanka K; Reincke Scarlett; Broeks Annegien; Braaf Linde M; Hogervorst Frans B L; Tollenaar Rob A E M; Johnson Nichola; Fletcher Olivia; Peto Julian; Tommiska Johanna; Blomqvist Carl; Nevanlinna Heli A; Healey Catherine S; Dunning Alison M; Pharoah Paul D P; Easton Douglas F; Dörk Thilo; Van't Veer Laura J;
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.
Cancer research 2007;67(19):9584-90.
2007: Ahlin C; Aaltonen K; Amini R-M; Nevanlinna H; Fjällskog M-L; Blomqvist C
Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?
Histopathology 2007;51(4):491-8.
2007: Pylkäs Katri; Tommiska Johanna; Syrjäkoski Kirsi; Kere Juha; Gatei Magtouf; Waddell Nicola; Allinen Minna; Karppinen Sanna-Maria; Rapakko Katrin; Kääriäinen Helena; Aittomäki Kristiina; Blomqvist Carl; Mustonen Aki; Holli Kaija; Khanna Kum Kum; Kallioniemi Olli-Pekka; Nevanlinna Heli; Winqvist Robert
Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Carcinogenesis 2007;28(5):1040-5.
2007: Ruijs Mariëlle W G; Schmidt Marjanka K; Nevanlinna Heli; Tommiska Johanna; Aittomäki Kristiina; Pruntel Roelof; Verhoef Senno; Van't Veer Laura J
The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.
European journal of human genetics : EJHG 2007;15(1):110-4.
2007: Amini Rose-Marie; Aaltonen Kirsimari; Nevanlinna Heli; Carvalho Ricardo; Salonen Laura; Heikkilä Päivi; Blomqvist Carl
Mast cells and eosinophils in invasive breast carcinoma.
BMC cancer 2007;7():165.
2006: Milne Roger Laughlin; Ribas Gloria; González-Neira Anna; Fagerholm Rainer; Salas Antonio; González Emilio; Dopazo Joaquín; Nevanlinna Heli; Robledo Mercedes; Benítez Javier
ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.
Cancer research 2006;66(19):9420-7.
2006: Nevanlinna H; Bartek J
The CHEK2 gene and inherited breast cancer susceptibility.
Oncogene 2006;25(43):5912-9.
2006: Johannsdottir Hrefna K; Jonsson Goran; Johannesdottir Gudrun; Agnarsson Bjarni A; Eerola Hannaleena; Arason Adalgeir; Heikkila Paivi; Egilsson Valgardur; Olsson Hakan; Johannsson Oskar Th; Nevanlinna Heli; Borg Ake; Barkardottir Rosa B
Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
International journal of cancer. Journal international du cancer 2006;119(5):1052-60.
2006: Kilpivaara O; Alhopuro P; Vahteristo P; Aaltonen L A; Nevanlinna H
CHEK2 I157T associates with familial and sporadic colorectal cancer.
Journal of medical genetics 2006;43(7):e34.
2006: Aaltonen K; Ahlin C; Amini R-M; Salonen L; Fjällskog M-L; Heikkilä P; Nevanlinna H; Blomqvist C
Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides.
British journal of cancer 2006;94(11):1697-702.
2006: Tommiska Johanna; Seal Sheila; Renwick Anthony; Barfoot Rita; Baskcomb Linda; Jayatilake Hiran; Bartkova Jirina; Tallila Jonna; Kaare Milja; Tamminen Anitta; Heikkilä Päivi; Evans D Gareth; Eccles Diana; Aittomäki Kristiina; Blomqvist Carl; Bartek Jiri; Stratton Michael R; Nevanlinna Heli; Rahman Nazneen
Evaluation of RAD50 in familial breast cancer predisposition.
International journal of cancer. Journal international du cancer 2006;118(11):2911-6.
2006: Vahteristo Pia; Syrjäkoski Kirsi; Heikkinen Tuomas; Eerola Hannaleena; Aittomäki Kristiina; von Smitten Karl; Holli Kaija; Blomqvist Carl; Kallioniemi Olli-Pekka; Nevanlinna Heli
BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
European journal of human genetics : EJHG 2006;14(2):167-72.
2006: Tommiska Johanna; Jansen Laila; Kilpivaara Outi; Edvardsen Hege; Kristensen Vessela; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Børresen-Dale Anne-Lise; Nevanlinna Heli
ATM variants and cancer risk in breast cancer patients from Southern Finland.
BMC cancer 2006;6():209.
2006: Vahteristo Pia; Yliannala Kristiina; Tamminen Anitta; Eerola Hannaleena; Blomqvist Carl; Nevanlinna Heli
BACH1 Ser919Pro variant and breast cancer risk.
BMC cancer 2006;6():19.
2005: Honrado Emiliano; Osorio Ana; Palacios José; Milne Roger L; Sánchez Lydia; Díez Orland; Cazorla Alicia; Syrjakoski Kirsi; Huntsman David; Heikkilä Päivi; Lerma Enrique; Kallioniemi Anne; Rivas Carmen; Foulkes William D; Nevanlinna Heli; Benítez Javier
Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7503-11.
2005: Tommiska Johanna; Eerola Hannaleena; Heinonen Mira; Salonen Laura; Kaare Milja; Tallila Jonna; Ristimäki Ari; von Smitten Karl; Aittomäki Kristiina; Heikkilä Päivi; Blomqvist Carl; Nevanlinna Heli
Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5098-103.
2005: Vézina Hélène; Durocher Francine; Dumont Martine; Houde Louis; Szabo Csilla; Tranchant Martine; Chiquette Jocelyne; Plante Marie; Laframboise Rachel; Lépine Jean; Nevanlinna Heli; Stoppa-Lyonnet Dominique; Goldgar David; Bridge Peter; Simard Jacques
Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families.
Human genetics 2005;117(2-3):119-32.
2005: Vahteristo P; Ojala S; Tamminen A; Tommiska J; Sammalkorpi H; Kiuru-Kuhlefelt S; Eerola H; Aaltonen L A; Aittomäki K; Nevanlinna H
No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.
Journal of medical genetics 2005;42(4):e22.
2005: Tukiainen Eija; Kylänpää Marja-Leena; Kemppainen Esko; Nevanlinna Heli; Paju Annukka; Repo Heikki; Stenman Ulf-Håkan; Puolakkainen Pauli
Pancreatic secretory trypsin inhibitor (SPINK1) gene mutations in patients with acute pancreatitis.
Pancreas 2005;30(3):239-42.
2005: Kiuru Maija; Lehtonen Rainer; Eerola Hannaleena; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli; Aaltonen Lauri A; Launonen Virpi
No germline FH mutations in familial breast cancer patients.
European journal of human genetics : EJHG 2005;13(4):506-9.
2005: Lempinen Marko; Paju Annukka; Kemppainen Esko; Smura Teemu; Kylänpää Marja-Leena; Nevanlinna Heli; Stenman Jakob; Stenman Ulf-Håkan
Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland.
Scandinavian journal of gastroenterology 2005;40(2):225-30.
2005: Kilpivaara Outi; Bartkova Jirina; Eerola Hannaleena; Syrjäkoski Kirsi; Vahteristo Pia; Lukas Jiri; Blomqvist Carl; Holli Kaija; Heikkilä Päivi; Sauter Guido; Kallioniemi Olli-Pekka; Bartek Jiri; Nevanlinna Heli
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.
International journal of cancer. Journal international du cancer 2005;113(4):575-80.
2005: Eerola Hannaleena; Heikkilä Päivi; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.
Breast cancer research : BCR 2005;7(4):R465-9.
2005: Eerola Hannaleena; Heikkilä Päivi; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.
Breast cancer research : BCR 2005;7(1):R93-100.
2004: Johannsdottir Hrefna K; Johannesdottir Gudrun; Agnarsson Bjarni A; Eerola Hannaleena; Arason Adalgeir; Johannsson Oskar T H; Heikkilä Päivi; Egilsson Valgardur; Olsson Hakan; Borg Ake; Nevanlinna Heli; Barkardottir Rosa B
Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
Anticancer research 2004;24(5A):2681-7.
2004: Kilpivaara Outi; Vahteristo Pia; Falck Jacob; Syrjäkoski Kirsi; Eerola Hannaleena; Easton Douglas; Bartkova Jirina; Lukas Jiri; Heikkilä Päivi; Aittomäki Kristiina; Holli Kaija; Blomqvist Carl; Kallioniemi Olli-Pekka; Bartek Jiri; Nevanlinna Heli
CHEK2 variant I157T may be associated with increased breast cancer risk.
International journal of cancer. Journal international du cancer 2004;111(4):543-7.
2004: Leinonen Jari; Niemelä Pauliina; Lövgren Janita; Bocchi Letizia; Pettersson Kim; Nevanlinna Heli; Stenman Ulf-Håkan
Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
Journal of immunological methods 2004;289(1-2):157-67.
2004: Huusko Pia; Juo Suh-Hang Hank; Gillanders Elizabeth; Sarantaus Laura; Kainu Tommi; Vahteristo Pia; Allinen Minna; Jones MaryPat; Rapakko Katrin; Eerola Hannaleena; Markey Carol; Vehmanen Paula; Gildea Derek; Freas-Lutz Diane; Blomqvist Carl; Leisti Jaakko; Blanco Guillermo; Puistola Ulla; Trent Jeffrey; Bailey-Wilson Joan; Winqvist Robert; Nevanlinna Heli; Kallioniemi Olli-P
Genome-wide scanning for linkage in Finnish breast cancer families.
European journal of human genetics : EJHG 2004;12(2):98-104.
2003: Kilpivaara O; Laiho P; Aaltonen L A; Nevanlinna H
CHEK2 1100delC and colorectal cancer.
Journal of medical genetics 2003;40(10):e110.
2003: Krop Ian; Maguire Paula; Lahti-Domenici Jaana; Lodeiro Gabriela; Richardson Andrea; Johannsdottir Hrefna Kristin; Nevanlinna Heli; Borg Ake; Gelman Rebecca; Barkardottir Rosa Björk; Lindblom Annika; Polyak Kornelia
Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
Cancer research 2003;63(9):2024-7.
2002: Vahteristo Pia; Bartkova Jirina; Eerola Hannaleena; Syrjäkoski Kirsi; Ojala Salla; Kilpivaara Outi; Tamminen Anitta; Kononen Juha; Aittomäki Kristiina; Heikkilä Päivi; Holli Kaija; Blomqvist Carl; Bartek Jiri; Kallioniemi Olli-P; Nevanlinna Heli
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
American journal of human genetics 2002;71(2):432-8.
2002: Rozenblum Ester; Vahteristo Pia; Sandberg Therese; Bergthorsson Jon Thor; Syrjakoski Kirsi; Weaver Don; Haraldsson Karin; Johannsdottir Hrefna Kristin; Vehmanen Paula; Nigam Savita; Golberger Natalie; Robbins Christiane; Pak Evgenia; Dutra Amalia; Gillander Elizabeth; Stephan Dietrich A; Bailey-Wilson Joan; Juo Suh-Hang Hank; Kainu Tommi; Arason Adalgeir; Barkardottir Rosa Bjork; Nevanlinna Heli; Borg Ake; Kallioniemi Olli-P
A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes.
Human genetics 2002;110(2):111-21.
2002: Eerola H; Aittomäki K; Asko-Seljavaara S; Nevanlinna H; von Smitten K
Hereditary breast cancer and handling of patients at risk.
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society 2002;91(3):280-7.
2001: Barkardottir R B; Sarantaus L; Arason A; Vehmanen P; Bendahl P O; Kainu T; Syrjäkoski K; Krahe R; Huusko P; Pyrhönen S; Holli K; Kallioniemi O P; Egilsson V; Kere J; Nevanlinna H
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families.
European journal of human genetics : EJHG 2001;9(10):773-9.
2001: Eerola H; Pukkala E; Pyrhönen S; Blomqvist C; Sankila R; Nevanlinna H
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).
Cancer causes & control : CCC 2001;12(8):739-46.
2001: Lahti-Domenici J; Rapakko K; Pääkkönen K; Allinen M; Nevanlinna H; Kujala M; Huusko P; Winqvist R
Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families.
Cancer genetics and cytogenetics 2001;129(2):120-3.
2001: Vahteristo P; Tamminen A; Karvinen P; Eerola H; Eklund C; Aaltonen L A; Blomqvist C; Aittomäki K; Nevanlinna H
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
Cancer research 2001;61(15):5718-22.
2001: Eerola H; Vahteristo P; Sarantaus L; Kyyrönen P; Pyrhönen S; Blomqvist C; Pukkala E; Nevanlinna H; Sankila R
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.
International journal of cancer. Journal international du cancer 2001;93(3):368-72.
2001: Sarantaus L; Vahteristo P; Bloom E; Tamminen A; Unkila-Kallio L; Butzow R; Nevanlinna H
BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
European journal of human genetics : EJHG 2001;9(6):424-30.
2001: Sarantaus L; Auranen A; Nevanlinna H
BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.
International journal of oncology 2001;18(4):831-5.
2001: Vahteristo P; Eerola H; Tamminen A; Blomqvist C; Nevanlinna H
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.
British journal of cancer 2001;84(5):704-8.
2001: Pääkkönen K; Sauramo S; Sarantaus L; Vahteristo P; Hartikainen A; Vehmanen P; Ignatius J; Ollikainen V; Kääriäinen H; Vauramo E; Nevanlinna H; Krahe R; Holli K; Kere J
Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.
Genetic epidemiology 2001;20(2):239-46.
2001: Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi O P; Nevanlinna H; Winqvist R
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
British journal of cancer 2001;84(1):116-9.
2000: Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi O P; Winqvist R; Nevanlinna H
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
European journal of human genetics : EJHG 2000;8(10):757-63.
2000: Syrjäkoski K; Vahteristo P; Eerola H; Tamminen A; Kivinummi K; Sarantaus L; Holli K; Blomqvist C; Kallioniemi O P; Kainu T; Nevanlinna H
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
Journal of the National Cancer Institute 2000;92(18):1529-31.
2000: Eerola H; Blomqvist C; Pukkala E; Pyrhönen S; Nevanlinna H
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?
European journal of cancer (Oxford, England : 1990) 2000;36(9):1143-8.
1998: Jahkola T; Toivonen T; Virtanen I; von Smitten K; Nordling S; von Boguslawski K; Haglund C; Nevanlinna H; Blomqvist C
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
British journal of cancer 1998;78(11):1507-13.
1998: Tapper J; Sarantaus L; Vahteristo P; Nevanlinna H; Hemmer S; Seppälä M; Knuutila S; Butzow R
Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32.
Cancer research 1998;58(13):2715-9.
1998: Roth S; Kristo P; Auranen A; Shayehgi M; Seal S; Collins N; Barfoot R; Rahman N; Klemi P J; Grénman S; Sarantaus L; Nevanlinna H; Butzow R; Ashworth A; Stratton M R; Aaltonen L A
A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.
British journal of cancer 1998;77(8):1199-202.
1997: Vehmanen P; Friedman L S; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi O P; Muhonen T; Luce M; Frank T S; Nevanlinna H
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Human molecular genetics 1997;6(13):2309-15.
1997: Vehmanen P; Friedman L S; Eerola H; Sarantaus L; Pyrhönen S; Ponder B A; Muhonen T; Nevanlinna H
A low proportion of BRCA2 mutations in Finnish breast cancer families.
American journal of human genetics 1997;60(5):1050-8.
1997: Muhonen T; Eerola H; Vehmanen P; Nevanlinna H; Aktan K; Blomqvist C; Kääriäinen H; Pyrhönen S
Breast cancer risk estimation in families with history of breast cancer.
British journal of cancer 1997;76(9):1228-31.
1994: Cropp C S; Nevanlinna H A; Pyrhönen S; Stenman U H; Salmikangas P; Albertsen H; White R; Callahan R
Evidence for involvement of BRCA1 in sporadic breast carcinomas.
Cancer research 1994;54(10):2548-51.
1993: Virtaneva K I; Nevanlinna H; Schröder J
BglII restriction fragment length polymorphism at the gene locus coding for the leukocyte surface antigen CD37.
Human molecular genetics 1993;2(8):1331.
1993: Jaakkola S; Salmikangas P; Nylund S; Partanen J; Armstrong E; Pyrhönen S; Lehtovirta P; Nevanlinna H
Amplification of fgfr4 gene in human breast and gynecological cancers.
International journal of cancer. Journal international du cancer 1993;54(3):378-82.
1993: Virtaneva K I; Angelisová P; Baumruker T; Horejsí V; Nevanlinna H; Schröder J
The genes for CD37, CD53, and R2, all members of a novel gene family, are located on different chromosomes.
Immunogenetics 1993;37(6):461-5.
1992: Nordström T; Nevanlinna H A; Andersson L C
Mitosis-arresting effect of the calcium channel inhibitor SK&F 96365 on human leukemia cells.
Experimental cell research 1992;202(2):487-94.
1990: Ala-Kapee M; Nevanlinna H; Mali M; Jalkanen M; Schröder J
Localization of gene for human syndecan, an integral membrane proteoglycan and a matrix receptor, to chromosome 2.
Somatic cell and molecular genetics 1990;16(5):501-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Heli Nevanlinna

Research Profile (preview)

Disorders

Physiology

Genes & Molecular Sequences

Geographic Areas

Chemicals & Drugs

Concepts & Ideas

Procedures

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Heli Nevanlinna (preview)

All Publications